Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Gregorio Benitez"'
Autor:
Athanasios Vassilopoulos, Fadi Shehadeh, Gregorio Benitez, Markos Kalligeros, Joanne S. Cunha, Cheston B. Cunha, Eleftherios Mylonakis
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Biologic (bDMARD) and targeted synthetic (tsDMARD) disease-modifying anti-rheumatic drugs have broadened the treatment options and are increasingly used for patients with psoriatic arthritis (PsA). These agents block different pro-inflamm
Externí odkaz:
https://doaj.org/article/9334775f7e744409af189e50a7fe5eb8
Autor:
Gregorio Benitez, Fadi Shehadeh, Markos Kalligeros, Evangelia K. Mylona, Quynh-Lam Tran, Ioannis M. Zacharioudakis, Eleftherios Mylonakis
Publikováno v:
Pathogens, Vol 11, Iss 5, p 555 (2022)
(1) Background: Clostridioides difficile infection (CDI) is associated with a high recurrence rate, and a significant proportion of patients with CDI are readmitted following discharge. We aimed to identify the risk factors for CDI-related readmissio
Externí odkaz:
https://doaj.org/article/be8503ff77ec4fb48bb946844f1003f9
Autor:
Yazed Saleh Alsowaida, Gregorio Benitez, Khalid Bin Saleh, Thamer A. Almangour, Fadi Shehadeh, Eleftherios Mylonakis
Publikováno v:
Antibiotics, Vol 11, Iss 3, p 375 (2022)
(1) Background: Ceftriaxone is a potential alternative for the treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bloodstream infections (BSIs) in acute care and outpatient parenteral antimicrobial therapy (OPAT) settings. We evaluated
Externí odkaz:
https://doaj.org/article/3a23e6b7328a4c28928cd121381bc7b6
Autor:
Fadi Shehadeh, Gregorio Benitez, Evangelia K Mylona, Quynh-Lam Tran, Maria Tsikala-Vafea, Eleftheria Atalla, Matthew Kaczynski, Eleftherios Mylonakis
Publikováno v:
The Journal of Infectious Diseases. 227:226-235
Background Thymosin-α-1 (Tα1) may be a treatment option for coronavirus disease 2019 (COVID-19), but efficacy and safety data remain limited. Methods Prospective, open-label, randomized trial assessing preliminary efficacy and safety of thymalfasin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13e39c0d560dda63c5932ec3795e6a25
https://doi.org/10.1093/infdis/jiac362
https://doi.org/10.1093/infdis/jiac362
Autor:
Matthew Kaczynski, Gregorio Benitez, Evangelia K Mylona, Quynh-Lam Tran, Eleftheria Atalla, Maria Tsikala-Vafea, Saisanjana Kalagara, Fadi Shehadeh, Eleftherios Mylonakis
Publikováno v:
Open Forum Infectious Diseases. 10
Background Clinical trials for coronavirus disease 2019 (COVID-19) have struggled to achieve diverse patient enrollment, despite underrepresented groups bearing the largest burden of the disease and, presumably, being most in need of the treatments u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38af1ac8afae33ac4d1e2ceb093899b8
https://doi.org/10.1093/ofid/ofad197
https://doi.org/10.1093/ofid/ofad197
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 20; Issue 1; Pages: 646
(1) Background: Respiratory co-infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other viruses are common, but data on clinical outcomes and laboratory biomarkers indicative of disease severity are limited. We aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b82a6c23fbfc752af498ec48534be4ed
https://pubmed.ncbi.nlm.nih.gov/36612967
https://pubmed.ncbi.nlm.nih.gov/36612967
Autor:
Gregorio Benitez, Fadi Shehadeh, Evangelia K. Mylona, Quynh-Lam Tran, Maria Tsikala-Vafea, Eleftheria Atalla, Matthew Kaczynski, Eleftherios Mylonakis
Publikováno v:
International Immunopharmacology. 116:109831
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a45797729773270c5fc6e202cbd502e
https://doi.org/10.1016/j.intimp.2023.109831
https://doi.org/10.1016/j.intimp.2023.109831
Autor:
Philip A. Chan, Fadi Shehadeh, Evangelia K. Mylona, Markos Kalligeros, Eleftherios Mylonakis, Gregorio Benitez
Publikováno v:
Am J Public Health
Objectives. To identify spatiotemporal patterns of epidemic spread at the community level. Methods. We extracted influenza cases reported between 2016 and 2019 and COVID-19 cases reported in March and April 2020 from a hospital network in Rhode Islan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8ae137709acf52dec9e0d8151537b1e
https://doi.org/10.2105/ajph.2020.305911
https://doi.org/10.2105/ajph.2020.305911
Autor:
Yazed Saleh Alsowaida, Gregorio Benitez, Khalid Bin Saleh, Thamer A. Almangour, Fadi Shehadeh, Eleftherios Mylonakis
Publikováno v:
Antibiotics; Volume 11; Issue 3; Pages: 375
(1) Background: Ceftriaxone is a potential alternative for the treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bloodstream infections (BSIs) in acute care and outpatient parenteral antimicrobial therapy (OPAT) settings. We evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9e1b85d46c7c7a306aee86c5fb997f9
Autor:
Evangelia K. Mylona, Fadi Shehadeh, Markos Kalligeros, Gregorio Benitez, Philip A. Chan, Eleftherios Mylonakis
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a7fdf69b696907c6bca8c02faa48a7b
https://doi.org/10.2139/ssrn.3576825
https://doi.org/10.2139/ssrn.3576825